MedTrace Logo

Fetal 3D Study (Fetal Body Composition and Volumes Study)

NCT03266198 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2809

Last updated 2022-01-13

No results posted yet for this study

Summary

Normal fetal growth is a critical component for a healthy pregnancy and for ensuring the health and well-being of infants throughout childhood and adolescence. One promising area of research suggests that changes in fetal soft tissue may be the earliest changes that occur in pathologic growth. Three-dimensional volume assessments may be used to detect changes in fetal lean mass, fat mass, and organ size that result from pathologic growth earlier than conventional 2D measures. This knowledge may lead to interventions that could minimize or prevent pregnancy and newborn health problems in the future.

Conditions

  • Fetal Growth Restriction
  • Fetal Growth Abnormality

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Baylor College of Medicine

    collaborator OTHER

  • Katherine Grantz

    lead NIH

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-27
Primary Completion
2019-09-15
Completion
2019-09-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03266198 on ClinicalTrials.gov